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CHAPTER I 
 
 
INTRODUCTION AND REVIEW OF RELEVANT LITERATURE 
 
1.1 The Impact of Diabetes and Vascular Complications 
The National Institute of Diabetes and Digestive Kidney Diseases estimates that 
20.8 million Americans (7% of population) have diabetes.[1] Oklahoma exceeds the 
national average with one in 10 oklahomans diagnosed as diabetic.  The Native American 
population within the state is particularly vulnerable to diabetes.  Since 1990, the 
prevalence of those diagnosed with diabetes increased 61%.[2]  Inherently associated 
with the western world as the rich man’s disease, past few years have seen an exponential 
rise in diabetic cases in developing countries as well.[3]  Changes in lifestyle [4] and food 
habits are often implicated to be the main reasons of this exponential growth. New York 
Times in June 2006 reported a total number of diabetics around the world to be 230 
million, a number which was 30 million 20 years back.[5]  The World Health 
Organization on their website project the number to reach 366 million by 2030.[6]  
Diabetes by itself is the fourth leading cause of death in most of the developed 
world and sixth in the USA.[1]  But complications associated with it prove diabetes 
epidemic [7] far more dangerous. Common complications associated with diabetes are 
hyperglycemia, atherosclerosis, myocardial infarction (heart attack), ischemia, 
thrombosis, high blood pressure, blindness, stroke, and limb amputation.  Diabetes is 
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often thought to be associated with an increased risk for atherosclerosis [8, 9] and also 
linked with many other vascular diseases [10].  
Atherosclerosis is a chronic inflammatory immunological disease characterized 
by formation of lipid laden plaques or lesions in the intima region of blood vessels.  
Plaque is made up of deposits of fatty substances, cholesterol, cellular waste products, 
calcium, and fibrin, and can develop in arteries.  These lesions are formed as a result of 
very specific cellular and molecular responses to various endogenous risk factors for 
atherosclerosis and antigenic stimuli.[11]  
As these plaques grow larger in size, they tend to block the blood flow, thereby 
causing further cardiovascular complications.  In atherosclerosis, plaque formation within 
blood vessels leads to ischemia (restriction in blood supply) that can cut or reduce blood 
supply to different tissues.  For example, in coronary artery disease, atherosclerosis 
narrows the coronary arteries, which are the arteries supplying blood to the heart muscle.  
With more narrowing, the risk of a heart attack (myocardial infarction), which occurs 
when a coronary artery is blocked completely, is increased.  Figure 1 shows how plaque 
formation and related phenomena, such as thrombosis, can affect the blood vessel(s) and 
lead to complications, such as myocardial infarction. When an atheroma is formed in an 
artery, it starts accumulating lipids and narrowing down the cross section of the vessel, as 
shown in figure 1.  This lipid filled plaque may become vulnerable and rupture, leading 
to thrombosis and a myocardial infarction. 
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Figure 1.  Development of an atherosclerotic plaque in a blood vessel.[12] 
Continuous, prolonged ischemia can also reduce the blood supply to tissues 
leading to tissue death.  This problem is common in limbs, which can result in limb 
amputations.[13]  In the atherosclerotic narrowed down arteries, a blood clot (thrombus) 
may form inside a brain artery, which can cut off the blood supply to part of the brain and 
cause a thrombotic stroke.  The ischemic damage depends on the size of the obstruction, 
its location, and the duration of the lesion formation.[14]  Plaques can also rupture and 
block the coronary arteries, thereby causing thrombosis and hence responsible for 
myocardial infarction in another way.  
Primary cause of morbidity and mortality in patients with diabetes is due to 
cardiovascular diseases (CVD) that affects both the micro- and macrovasculature.[15] 
Since diabetes is often thought to be associated with an increased and accelerated risk for 
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atherosclerosis [8, 9], patients with diabetes have a much higher risk of diseases like 
myocardial infarction, stroke and limb amputation.  Epidemiological studies have shown 
that diabetics are at 1.5- to 3-fold greater risk of atherosclerotic disease and a two-fold 
higher risk of myocardial infarction.  Diabetic women are five-fold more prone to 
coronary artery disease than the general population.[16]  The treatment costs attributable 
to diabetes are enormous and continue to grow.  A 2002 study showed that in U.S. alone, 
the direct and indirect costs attributed to diabetes was $132 billion.[17]  To look at the 
share of CVD complications in these costs, a study conducted in one managed healthcare 
system revealed that more than 25% of the excess costs of diabetes were due to 
cardiovascular disease complications, including atherosclerosis.[18]  Over the past two 
decades, progress has been made in defining the cellular and molecular interactions 
involved that connect diabetes to the development of atherosclerosis plaque.  The 
following describes the most recent understanding of how the two are related.  
Atherosclerosis is considered a chronic disease triggered by endothelial injury and 
sustained by inflammation.  All forms of diabetes are characterized by chronic 
hyperglycemia.  Hyperglycemia has been shown to be an inflammatory mediator that can 
affect both endothelial and immune cells.  Therefore, it is logical to investigate possible 
links between hyperglycemia and both endothelial and immune cell function.  In order to 
understand these possible links, a discussion of hyperglycemia, endothelial cells and 
immune cells will follow. 
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1.2 Chronic Hyperglycemia Associated with Diabetes 
Hyperglycemia is a condition in which the blood glucose level is elevated, or an 
excessive amount of glucose circulates in the blood plasma.  Glucose levels in the blood 
can vary within the same day, depending on food intake and body metabolism.  Because 
of this, there is no single way to express glucose concentration in blood.  Fasting blood 
sugar (or fasting blood glucose) is the most common term used to describe blood glucose 
levels.  Fasting blood glucose is defined as the concentration of glucose in blood at least 
eight hours after food has been eaten.  In general, the normal blood glucose range for 
most fasting adults (normoglycemia) is about 80 to 120 mg/dL or 4 to 7 mmol/L.  A 
subject with a consistent glucose level above 126 mg/dL or 7 mmol/L is considered to 
have hyperglycemia, whereas a consistent level below 70 mg/dL or 4 mmol/L is taken as 
hypoglycemic case.  
Normally, blood glucose level does not remain constant throughout the day, but 
varies as we take in food and as it circulates to different cells.[19]  The glucose 
concentration in blood is regulated by the secretion and action of the hormone insulin.  
An insufficient production/secretion or an ineffective action of this hormone makes the 
glucose concentration rise in the blood, as in the case of diabetes mellitus.  Insulin 
regulates uptake of glucose from the blood into the cells for the use as a fuel or for 
storage as glycogen in the liver.  
 
1.3  Blood Vessels and Endothelial Cells 
The vascular system is responsible for carrying blood to and from different tissues 
in the body.  The blood vessel network in itself is vast and if placed end to end, would 
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cover 50,000 miles.[20]  It is a closed circular system, with the heart pumping the blood 
through the blood vessels.  Blood vessels are grouped as arteries, veins and capillaries, 
and vary by size.  Usually, the diameter of the veins is the largest (20 µm to 13 mm), 
followed by the arteries (10 µm to 3 mm) and capillaries being the smallest (5µm to 10 
µm) [21].  The only exception is the aorta, which has an average diameter of 25 mm, 
making it the largest blood vessel (and artery) in the circulatory system. 
Arteries and veins consist of a coat of longitudinal smooth muscle (tunica 
externa), which surrounds an inner coat of circular smooth muscle (tunica media).  The 
inner surface is lined with a single layer of endothelial cells, the tunica intima.  Figure 2 
shows this layered structure of a typical blood vessel. 
 
Figure 2.  Layered structure of a typical blood vessel [22]. 
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All blood vessels at their inner surface are lined with specialized cells called 
endothelial cells.  This thin layer of confluent endothelial cells is called an endothelium 
and acts like a selective barrier between the blood stream and the tissues.  The endothelial 
cells are not flat but protruding at the center and tapering towards the edges.  When 
completely confluent, the endothelial cell layer has a characteristic cobblestone layer 
look.  The endothelial cells spread over the whole circulatory system from the smallest 
capillary to the heart.  The endothelial cells serve as the regulators of transport through 
the endothelium [23] and through the blood vessel wall.  Vascular endothelium, due to 
their position between the blood and tissue, are able to sense changes in hemodynamic 
conditions and biochemical stimuli and are designed to respond to these fluctuations by 
regulating the cytokine microenvironment, upregulating adhesion molecules on cell 
surfaces, angiogenesis, etc.[24]  There exist tight junctions between any two adjoining 
endothelial cells, the permeability of which are modulated by a number of stimuli.[23]  
Vascular endothelium is surrounded by a fibrous basement membrane after which lies the 
extracellular matrix (ECM) of the tissues.  ECM composition, just like most other 
biological parameters, varies with time and local conditions.  The ECM is predominantly 
composed of collagen, elastin, laminin, fibronectin, and heparan-sulphate proteoglycans 
with collagen being the most abundant.[25-27]  As the blood cells flow through the blood 
vessels, they interact with the surface characteristics of the endothelium.  Before 
describing these interactions, it is important to know a little about the blood, its 
composition and function. 
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1.4 Blood and Leukocytes 
Table 1 gives an overview of the physical properties of blood.  Blood is the thick, 
red fluid that provides oxygen, nourishment, and protection to the cells and carries away 
waste products.  There is approximately five liters of blood in an average adult human.  
The whole blood consists of two major components: the plasma and the cellular 
components.  Plasma makes up about 55% of the whole blood and the remaining 45% 
being the blood cells.  Plasma is a straw colored liquid found in blood and lymph.  It is 
about 90% water with the remaining being nutrients, gases and waste products.[28]  The 
blood cells are found floating in the plasma along with certain other constituents of the 
blood like amino proteins, vitamins, and waste materials.  
Table 1. Physical Properties of Human Blood [29]. 
Property Value 
Whole Blood pH 7.35-7.4 
Viscosity (370C) 3.0 cP (at high shear stress) 
Specific gravity (25/40C) 1.056 
Whole Blood Volume ~78 ml/kg body weight 
RBC Count 4.8-5.4 *109/ml whole blood 
RBC average life span 120 days 
WBC Count ~7.4*106/ml whole blood 
WBC Diameter 7-20 microns 
Platelets Count ~2.8*108 ml whole blood 
Platelets Diameter ~2-5 microns 
 
 8 
Blood cells are often characterized as red blood cells (RBCs), white blood cells 
(WBCs) and platelets.  Red blood cells, also known as erythrocytes, make up more than 
90% of the blood cells, thus approximately 40% of whole blood volume.  Their function 
is to transport oxygen to the cells and carbon dioxide away from cells. Thus, red blood 
cells also play a big role in regulation of blood acidity.[21] 
White blood cells, also called the leukocytes, are immune cells important for the 
body’s immune response to foreign invaders and antigens.  White blood cells have a life 
cycle from a few days to a few weeks in supporting environment.  White blood cells can 
be divided into the following five groups: neutrophils, monocytes, lymphocytes, 
eosinophils, and basophils.  Table 2 describes the individual functions of each type of 
WBCs. 
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Table 2. The Types of White Blood Cells. 
Leukocyte 
Type 
Percentage 
of total 
WBCs 
Function Granularity 
Neutrophils 40-75% Fight disease by phagocytosis; very 
important against bacterial/fungal 
infection. 
Granular 
Monocytes ~6% Fight disease by phagocytosis; develop 
into macrophages or dendritic 
cells(DCs) on entering tissues; Largest 
of WBCs 
Agranular 
Lymphocytes 
-B cells 
-T cells 
-NK cells 
~30% Produce antibodies and chemicals that 
are active in regulating disease, 
allergies, and controlling tumors. 
Agranular 
Eosinophils ~3% Capable of phagocytic activity and 
release chemicals during inflammation; 
their number increases greatly with 
parasitic infections or allergic 
reactions. 
Granular 
Basophils ~1% Target allergic reactions. Granular 
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1.5 Interactions Between the Blood Endothelium and the Leukocytes 
Leukocytes are involved in body’s immune response and travel to all the tissues 
of the body.  These cells tend to migrate through the endothelium into the interstitial 
tissue (intima) from the lumen; this process is called transendothelial migration.  
Constitutive migration of monocytes from the blood is important to ensure the 
replenishment of the macrophage numbers within the tissue.  But compared to the 
unstimulated/non inflamed state, this migration is enhanced drastically whenever they 
sense a local inflammation.[30-33]  Inflammation could be caused by pathogens, 
infection, damage to the tissues, or a combination of those, and is the body’s response to 
fight back these attacks.  Figure 3 shows the cross section of a blood vessel and the 
physiology of leukocytes in the case of inflammation. 
 
Figure 3.  Cross sectional view of a blood vessel describing leukocyte rolling, 
adhesion, diapedesis,  and transendothelial migration in response to various stimuli 
within the tissue.[34, 35] 
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   Leukocytes inspect the tissues for potential bacterial, antigenic, tissue injury or 
other possible “inflammatory signs” and respond by phagocytosis of possible cell debris 
and pathogens.  Transendothelial migration of leukocytes is regulated by the local 
microenvironment of the endothelium and the cell phenotype, in a process where cell 
adhesion molecules present on both the leukocytes and endothelial cells play an 
important role.[25, 36, 37]  The process of the leukocyte interaction with the endothelium is 
known as the leukocyte cell adhesion cascade and is a multistep orchestrated process.  
Inflammation affects each of these steps from up-regulation of adhesion molecules on local 
endothelium to subsequent migration and possible complications.  The whole process is still 
not completely clear, but is believed to be responsible for the local recruitment of leukocytes 
to sites of inflammatory challenge.  Inflammation results in endothelial activation, which 
is considered as a crucial step in the initiation of atherosclerosis process, as well as in the 
development of advanced atherosclerosis.  Stimulation of endothelial cells with pro-
inflammatory cytokines has been found to increase the expression of adhesion molecules 
such as intracellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion 
molecule-1 (VCAM-1).[38]  Amongst other agents and conditions, high glucose 
(hyperglycemia condition) has been found to be a proinflammatory signal and contribute 
to the inflammatory response.[39, 40]  The inflammatory response evoked by glucose is 
associated with an upregulated leukocyte-endothelium interaction, potentially achieved 
by upregulated cell adhesion molecule (CAM) expressions.  
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     1.5.1 Cell Adhesion Molecules 
Cell adhesion molecules are proteins located on the cell surface and are involved 
with the binding to other cells or with the extracellular matrix (ECM).  The adhesion 
molecules are classified as four types, based on their structural and biochemical 
characteristics, as integrins, cadherins, selectins and members of the immunoglobulin 
superfamily.  The selectins and members of the immunoglobulin superfamily have shown 
key roles in atherosclerosis. 
Selectin family of cell adhesion molecules are the ones that are involved in the 
recruitment of leukocytes in the event of an injury or inflammation.  There are several 
types of selectins, including the P-, E-, and L-selectins. E-selectin or endothelial-
leukocyte adhesion molecule-1 (ELAM-1) has been identified as participating in the 
rolling and adhesion of monocytes and neutrophils.[14, 25, 41-43]  It is synthesized 
during inflammation only and hence will not be expressed on unstimulated endothelial 
cells, but only on stimulated conditions like in atherosclerotic lesions or after being 
stimulated by cytokines.[14, 41, 44]  L-selectin is another important CAM,  expressed at 
the tips of microfolds on granulocytes, monocytes, and a vast array of circulating 
lymphocytes.[45]  However, L-selectin cannot by itself assume the rolling task at normal 
velocities in vivo [45] (happening within the living body), thereby needs the participation 
of either P- or E-selectin. 
 Immunoglobulin superfamily is a very important class of cell adhesion 
molecules.  It is characterized by an immunoglobulin subunit and is involved in antigen 
recognition.[14]  Some common CAMs under this category are ICAM-1, VCAM-1 and 
platelet endothelial cell adhesion molecule (PECAM-1).  ICAM-1 is a transmembrane 
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glycoprotein immunoglobulin continuously present in lower concentrations in the 
membranes of leukocytes and endothelial cells.  In the event of stimulation by 
inflammation or by cytokines IL-1 and TNF-α, the concentration greatly increases and is 
expressed by vascular endothelial cells, macrophages and lymphocytes.  Another 
immunoglobulin is VCAM-1.  In atherosclerotic plaques, VCAM-1 expression is 
upregulated possibly by TNF-α and IL-1, while in unstimulated HUVECs, it is minimally 
expressed.[46]  PECAM-1, a transmembrane protein, is expressed at the junctions of the 
ECs [37, 43] and also to a lower degree at the surface of immune cells like macrophages, 
neutrophils, monocytes, lymphocytes, etc. [37].  PECAM-1 is crucial in the process of 
leukocyte transmigration through intercellular junctions of HUVECs.  Pretreating either 
the leukocyte or the endothelial cells with a PECAM-1 blocking antibody is shown to 
reduce the transendothelial migration by 70-90%.[47]  The leukocytes are seen to be 
trapped precisely over the intercellular HUVECs junctions, after they are treated with a 
blocking antibody, thereby blocking the transmigration.[47, 48] 
 
     1.5.2 Movement of Leukocytes into the Tissue in Inflammation: Leukocyte 
Adhesion Cascade 
On sensing an inflammatory condition, the leukocytes are quickly recruited to 
fight the infection/antigen.  In order to fight, the leukocytes need to migrate within the 
intima.  This movement of the leukocyte into the intima is called the cell adhesion 
cascade and it is governed by many factors, with some known and some unknown.  This 
cascade consists of the endothelial cells and leukocytes interacting in response to an 
inflammatory condition.  The process consists of different stages like leukocyte rolling, 
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leukocyte adhesion and then firm adhesion, followed ultimately by transendothelial 
migration.  Figure 4 shows the leukocyte adhesion cascade.  
 
Figure 4.  Schematic of the multistep paradigm of leukocyte recruitment.[49] 
Rolling is seen to begin as the selectin molecules present in leukocytes and 
endothelial cells constantly form and break bonds.[41, 50]  The selectin molecules thus 
decelerate the moving leukocytes until they come to a stop and adhere on to the 
endothelial junctions.  This step of adhesion is seen to be motivated by the signals from 
the endothelial cells and involves selectins and immunoglobulin family CAMs like 
VCAM-1 and ICAM-1.  The final step of the leukocyte adhesion cascade is the 
transendothelial migration of the leukocytes and is believed to involve ICAM-1 
expression by the endothelial cells as ICAM-1 is found on both the apical and basal 
surfaces of the endothelial cells.[51]  
 
 
 15 
1.5.3 Monocyte Differentiation and Reverse-Transmigration Across the 
Endothelium 
One type of the leukocytes, called monocytes, actively accumulate within the 
intima and some of these differentiate further into macrophages and dendritic cells.  
These macrophages are responsible for the clearance of unphysiologic proteins, debris, 
and lipids through phagocytosis.  Macrophages are also involved in the secretion of 
growth factors, cytokines, and chemoattractants, which facilitate further recruitment of 
monocytes.  Some of the migrated monocytes that differentiate into dendritic cells move 
from the tissues into the draining lymphatics to present antigen in the lymph nodes, 
through a process called reverse-transmigration.  In reverse-transmigration, cells move 
across the endothelium from the basolateral to the apical direction.[52]  Molecular 
mechanisms behind migration of DCs to the lymphatics are not very well understood.[25]  
Migration from the tissues into lymph nodes requires passage across the endothelium of 
the afferent lymphatic vessel [53], however there is little information on how DCs cross 
this barrier in vivo. Recently though, p-glycoprotein (PgP/MDR-1), a membrane 
transporter molecule, has been identified as playing an important role in attaining 
reverse-transmigration [54]. Antibodies against p-glycoprotein were found to impair 
reverse-transmigration by DCs in vitro (outside the living body).[55]  
 
1.5.4 The Effect of Flow on Endothelial Cell Behavior  
Blood in the vessels follow a pulsatile non-Newtonian flow.  The vessels branch 
out into tapering daughter vessels as they extend into a wider network.  There is an 
increase in cross sectional area due to branching.  The blood vessels are curved, and 
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blood vessel curvature has a profound effect on flow.[23]  As a result o f this curvature 
and varying cross-section, adverse pressure gradients are produced that cause flow 
reversal and the velocity profile in these Y shaped branching regions is skewed.[23]  
Such regions are called shoulder regions.  Figure 5 shows the velocity profile associated 
with such a region.  The lines closer to the Y shaped region appear to have a far more 
disturbed velocity profile as compared to the ones far away from it.  The last two lines 
situated just before and after the Y shaped region, show the most disturbed velocity 
profile.  These regions are like the arterial curvature and branch points.  Atherosclerotic 
lesions have been found to develop in these regions of arterial curvature and branch 
points.[56]  The flow in these regions is disturbed and non uniform.  Also the expression 
of certain proinflammatory genes (cell markers) implicated in atherogenesis (formation of 
atheromatous lesions in the intima) was found to be increased.[56]  
 
Figure 5.  Velocity profile associated with a shoulder region in a blood vessel.[57]  
Away from vessel branches, endothelial cells are elongated.  Figure 6 describes 
the blood flow in an atherosclerosis-prone (AP) and atherosclerosis-resistant(AR) region 
of the endothelium.[58]  The endothelial cells in the AP region appear rounder and do not 
 17 
have one distinct orientation, unlike the AR region endothelial cells, which are all 
oriented towards the blood flow direction.  There are a significant number of leukocytes 
attached to the surface of endothelium in AP areas, as against the AR regions.  These type 
of AP regions exist around the shoulder region where the flow is found to be disturbed, 
while the AR regions are the ones with the normal blood flow.  
 
 
Figure 6.  Endothelial cell spread morphology describing an atherosclerosis prone 
(AP) region and an atherosclerosis resistant (AR) region in an in vivo human aorta 
model. Scale bars: 15 µm.[58] 
 
1.6 Link between Hyperglycemia and Atherosclerosis 
In atherosclerosis, the inflammatory response is mediated by functional changes 
in a host of different cell types, including endothelial cells, T lymphocytes, monocyte-
derived macrophages and smooth muscle cells.[59]  Activation of these cells leads to the 
complex array of inflammatory events consisting of the release of hydrolases, cytokines, 
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chemokines, adhesion molecules, and growth factors, together with lipid accumulation 
and proliferation of smooth muscle cells and fibroblasts.  Leukocytes move into the site 
of inflammation within the vascular intima by way of adhesion molecules, such as 
VCAM-1.  Monocytes differentiate into macrophage or dendritic cells (DCs), depending 
on certain factors.  These factors depend on the microenvironment surrounding the cells 
[60], but this phenomenon is not completely clear.  When activated, macrophages also 
express multiple scavenger receptors that facilitate internalization of modified 
lipoproteins leading to the development of cholesterol-laden foam cells and plaque 
formation in arteries [61], as shown in Figure 7. 
 
Figure 7.  Recruitment of leukocytes to the nascent atherosclerotic plaque.[12] 
Since hyperglycemia is found to be a proinflammatory signal [39, 40], it could 
actually be upregulating the cell adhesion molecules on endothelium and leukocytes [62]. 
Leukocyte adhesion, rolling and migration is enhanced drastically whenever they sense a 
local inflammation.[30-33]  Thus, the initial stages of atherosclerosis could actually be 
related to an increased expression of the cell adhesion molecules that allow more 
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monocytes to come into contact with endothelial cells leading to an increase in migration 
into the tissue and differentiation to macrophages.  In vivo studies done on a rat model 
revealed that leukocyte rolling and migration through the endothelial cells was increased 
when subjected to hyperglycemia.[40]  Also , an associated increase in the expression of 
certain CAMs  on ECs was observed after exposure to hyperglycemia in this in vivo rat 
model.[40]  
It was important to know whether the effects were due to hyperglycemia or some 
other factors associated with glucose, such as hyperosmolarity.  Some studies have 
therefore investigated the effect hyperosmolarity has on hyperglycemia-atherosclerosis 
associated phenomena.  To check this, a hyperosmolar control, mannitol, was employed 
in various studies to see if the presence of an equally hyperosmolar group produces a 
similar activation of the endothelial cells.  Mannitol was found to give no significant 
difference within the tested concentration and incubation time ranges for monocyte 
binding [63], leukocyte adhesion [64-66], VCAM-1 expression [67], ICAM-1 expression 
[65], monocyte migration [68, 69], and endothelial cell apoptosis [70, 71]. 
There have been studies to characterize atherosclerotic lesions by investigating 
different CAM expressions, such as ICAM-1 and VCAM-1.[72]  PECAM-1 expression 
has been found to be elevated with severe atherosclerosis and PECAM-1 expression has 
been detected in atherosclerotic plaques.[73]  Similar upregulation of VCAM-1 
expression on HUVECs and on atherosclerotic plaques was observed for in vivo 
atherosclerotic studies.[46, 74]  The expression of ICAM-1 was also found upregulated 
significantly in the earlier stages of atherosclerosis when the vascular endothelium was 
still intact.[75] 
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Atherosclerosis has many inflammation-mediated risk factors like hyperglycemia, 
abdominal obesity, tobacco smoking, dyslipidemia, bacterial and viral infection, 
hyperhomocysteinemia.[56, 76]  In some of the in vivo animal studies, hyperglycemia has 
been shown to enhance atherosclerotic plaque growth [8], but the exact cellular 
mechanism is not clear.  The common trends associated with both hyperglycemia and 
atherosclerosis-like enhanced leukocyte adhesion and CAM expressions add up to the 
possibility of a link between the two. 
   
1.7 Comparison of Biological Model Systems  
Studying the transient and complex conditions associated with biological systems 
often involves the use of complex experimental systems.  Much work has been done to 
develop better in vivo (happening within the living body) and in vitro (outside the living 
body) systems to study such conditions.  Figure 8 gives an overview of systems available 
for studying biological phenomena including the human models, animal models, two-
dimensional (2D) cell culture models or three-dimensional (3D) tissue-engineered 
models. 
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Figure 8.  Different Systems Available to Study Normal and Pathological 
Physiological Mechanisms. 
 
     1.7.1 Advantages and Disadvantages of the Model Systems 
The human model is the best model to test various mechanisms, as it contains all 
the right “parts” and provides the exact microenvironment directed towards human 
physiology testing; however, they have some major drawbacks.  They are very difficult to 
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control, owing to their complexity.  Due to the presence of a multi-variable environment, 
it is difficult to study one variable or one system at a time, or isolate the contribution of 
one single variable to the overall effect.  Human models are prone to high variability.  
This is acceptable when used as a predictor for total population analysis, but this is a 
problem when trying to study the effect of one single variable at a time, while keeping all 
others constant.  The biggest drawback of the human model is that it cannot be used to 
study anything that will have potential health hazards to the model. 
Animal models, like human models, offer complexity, but are better in the respect 
that the variability can be more easily controlled by using bred animals for research.  
Also, under the right government regulations, they can be used to study potential health 
hazards to the model.  The problem with animal models is that they do not always 
translate to the human model, and need further validation.  Animal models can also have 
the complexity associated with isolating the contribution of one single variable from the 
overall effect.   
Two-dimensional cell culture models may not have the same level of complexity 
as the human and animal models, but they are widely used because of many advantages 
associated with them.  They are relatively inexpensive and easy to create and maintain.  It 
is also far easier to control the variables in cell culture models.  Human cells, can be used 
in 20 cell culture models, which helps in attaining a very similar microenvironment like 
the one found in vivo.  Due to this relatively less complexity, it is easier to look at the 
individual contribution(s) of any single variable, while keeping all other variables 
constant.  
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A 3D tissue engineered model takes the 2D systems from the bare minimum to 
the next level of complexity, while still maintaining the advantages of being inexpensive, 
easier to control, and easier to build.  Also, the 3D models are suspected to behave closer 
to the in vivo conditions than the less complex 2D models.  This behavior is often owing 
to the extra dimension involved, which influences signaling and certain other cellular 
functions.  A 3D model thus appears to describe real system biological phenomena more 
closely than its 2D counterpart. 
 
     1.7.2 In vivo Versus In vitro Model Systems  
The ideal approach for experimental science is to have control over all the 
variables in order to study the effect of individual variables or combination of variables 
on the system.  When it comes to studying biological phenomena in vivo, such models 
can have some disadvantages associated with them.  It becomes difficult to find 
homogenous group of samples in vivo (or subjects in clinical studies).  Also, it becomes 
even more difficult to maintain the homogeneity of the samples as an experiment 
progresses, due to the lack of ability to modulate these in vivo systems.  Thus to study the 
effect of any single factor is difficult, time consuming and more costly in the in vivo 
systems.  As a remedy to this, the importance of in vitro systems is realized.  In vitro 
systems can be difficult to design [25], but once designed are easy to be replicated.  Also, 
it is easier to maintain homogenous conditions all throughout an experiment.  Unlike an 
in vivo system like in an animal/human model, where more than one complex 
physiological, immunological and extra-cellular matrix interactions interfere with each 
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other’s effects, in vitro systems can be used to look at the change in one specific 
parameter.[77]  
Also, cost becomes an important factor when comparing in vivo with in vitro 
models.  Prescription drugs are expensive by design, as they cost a lot to develop but are 
relatively cheaper to make.[78]  According to the pharmaceutical industry's trade group, 
Pharmaceutical Research and Manufacturers of America (PhRMA), developing a single 
new drug and bringing it to market takes on average 12-15 years and costs $500 
million.[79]  Figure 9 represents the main areas and their associated costs involved with 
bringing a drug to the market.  If drug testing had fewer numbers of trials and quicker 
approvals, they would have less expenses involved, with getting a drug to the market.  
The two main areas that a better testing model can positively impact are the basic pre-
clinical research used to identify candidates and efficacy trials.  In-vitro tests are 
necessary to help determine initial dose-response data, as well as to evaluate potential 
susceptibility and/or resistance of specific pathogens.[80]  The employment of 
appropriate in vivo animal testing is vital prior to clinical evaluations.  Due to this reason 
in vitro tests are conducted prior to running in vivo tests.  Along with helping to reduce 
costs, the development of better in vitro models can also possibly reduce the amount of 
testing that would need to be performed on animals and humans. 
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Figure 9.  Steps and costs associated with bringing a new drug to market. The 
advantages of using an in vitro model are highlighted at the decision gates. 
 
     1.7.3 Two-Dimensional Versus Three-Dimensional Model Systems 
Tissue culture and cell biology research frequently depends on being able to 
create in vitro environments that can mimic the in vivo conditions.  Using artificial 
substrates such as plastic or glass are likely to distort findings by forcing cells to adjust to 
artificially flat and rigid surfaces.[81]  The current understanding of cell-matrix 
interactions in vitro is primarily based on planar 2D tissue culture substrates.  Relatively, 
little is known about cell-matrix adhesive structures formed in 3D matrices of living 
tissues.  In vivo cells attach to surrounding 3D mesh-like fibers rather than to 2D coated 
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surfaces.  In 2D coated cell culture surfaces, this attaching and further spreading is 
hindered or morphed, due to changes in the biophysical properties like a hard surface 
beneath.  Due to these different biophysical properties involved, signaling and certain 
other cellular functions have been shown to differ in 3D compared to 2D planar 
systems.[82]  The differentiation of monocytes was studied on 3D collagen gels and was 
found to have a rapid differentiation rate (1.5 times faster) than compared to 2D collagen-
coated plastic layer.[83]  Importance of a 3D ECM is already recognized for certain types 
of cells, like epithelial cells, where 3D environments promote normal epithelial polarity 
and differentiation.[84]  Another example is culturing fibroblast cells on flat substrates 
induces an artificial polarity between the lower and upper surfaces of these otherwise 
nonpolar cells.  The morphology and migration of these cells differs from 2D planar 
surfaces than when suspended in 3D collagen gels.[81, 85]  Cells also have been shown 
to have an enhanced migration rate (~1.5 times) in 3D models than 2D planar protein 
coated surfaces.[86]  The time taken by cells to reach their characteristic in vivo 
morphology is considerably lesser in 3D collagen gels.[86]  Thus, it is quite certain that a 
3D model would be able to describe biological phenomena more closely as a real system 
than its 2D counterpart. 
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1.8 Present Studies on Atherosclerosis and Hyperglycemia in Different Systems 
     1.8.1 In vivo Models 
Studies done on an in vivo rat model revealed that leukocyte rolling and migration 
through the endothelial cells was increased when subjected to hyperglycemia.[40]  Also, 
an associated increase in the expression of certain CAMs  on EC was observed after 
exposure to hyperglycemia in this in vivo rat model, thereby reinforcing the possible 
relation between an increased leukocyte adhesion and enhanced CAM expressions.[40]  
Clinical observations and epidemiological studies clearly indicate that atherosclerosis is 
accelerated in diabetic patients.[87]  Since, diabetes is characterized by hyperglycemia, a 
possible link between atherosclerosis and hyperglycemia has been sought.  Studies on 
human artery segments from diabetic and non-diabetic patients have been used to identify 
any difference in CAM expressions of ICAM-1,VCAM-1 and E-selectin.[72]  These 
studies have clearly shown an enhanced VCAM-1 expression on endothelial cells.  Other 
studies have shown an enhanced expression of ICAM-1 and VCAM-1 on atherosclerotic 
lesions found in aortas.[72] 
 
1.8.2 Two-Dimensional Solid Surface Models 
In vitro studies using 2D models imitating a blood endothelium are common as 
well.[88]  Common in vitro models employed to study the blood endothelium includes 
culture of endothelial cells on flat plastic surfaces.[25]  Endothelial cells were selected 
from different sources within the body, like blood brain barrier [89], umbilical cord [68, 
90], and valves [91] depending on the specific application of the model.  The cells are 
cultured on plastics coated with thin layers of common ECM proteins like laminin, 
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fibronectin, or collagen.[83, 89]  A 2D ligand coated surface would involve different cell 
interactions, associated signaling, and gene expression regulating differentiation into 
different phenotypes than a complex 3D architecture.[92]  Also, such 2D studies only 
investigate rolling (for a flow system) or adhesion of monocytes on endothelial cells, and 
do study the transendothelial migration of monocytes. 
 
1.8.3 Two-Dimensional Culture Inserts 
In an attempt to study transendothelial migration of monocytes through the 
endothelium, models were created by using tissue culture inserts in multiwell plates.[93]  
These are also called within Transwell® chambers.  Figure 10 shows an example of tissue 
culture inserts used within multiwell plates (or a Transwell® chamber).  These models 
have two chambers separated with a porous membrane.  A cell suspension is put in the 
upper chamber and migration across the membrane to the lower membrane is studied.  
The membrane may or may not have a confluent cell layer on its surface.  For the case of 
monocyte migration across an endothelium, endothelial cells are grown to confluency on 
the membrane and monocytes are added to the top chamber to investigate migration 
across the endothelium.  A small sample can be drawn out from the lower chamber at 
different time points, and the number of these cells can be counted.  These inserts have 
polyethylene terephthalate (PET) membranes, which give the membranes the advantage 
of being mechanically durable and curl free.  Other advantages associated with these 
types of models are that owing to their transparent/translucent nature, they can be used 
directly for light microscopy, electron microscopy and immunofluorescence.  
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Figure 10.  Multiwell plates with tissue culture inserts are commonly used to study 
cell migration.[94] 
Missing in these models are the interactions between cells and the extra-cellular 
matrix (ECM).  Mechanical properties of the ECM are critical in regulating cellular 
signaling.[95]  Integrins, which are known to bind endothelial cells to the subendothelial 
matrix through the cytoskeletons [14], have an effect on signal transduction (a process by 
which a cell transforms one kind of signal or stimulus into another).  Artificial substrates 
such as plastic or glass distort findings by forcing cells to adjust artificially to flat and 
rigid surfaces.[81]  Another drawback of using the tissue culture inserts was that once the 
cells migrated across the endothelium, they were committed to the bottom of the well 
plate and did not have the ability to freely migrate within the subendothelium intima.  
The ability to study diseases like atherosclerosis, by including potential atherosclerosis 
promoting lipid in media, was not possible due to the absence of an ECM to make up a 
subendothelium intima in the model. 
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1.9 Development of a Better Model System: The Three-Dimensional Tissue Model 
Unfortunately, the 2D models cannot capture the trans-endothelial migration at 
any given time point, and monocyte differentiation cannot be investigated.  Monocytes 
differentiate into either macrophages or dendritic cells depending on a number of known 
and unknown, and possibly interrelated factors.  Also, the possibility of studying 
hyperlipidemia, and thereby expecting plaque formation, is also not feasible in 2D 
models.  A need exists for developing 3D tissue models that can closely mimic the 
physiology and transient conditions associated with blood endothelium and leukocyte 
trafficking and differentiation.  Such a model would be a significant research tool in 
studying different conditions associated with inflammation and their possible roles 
towards atherosclerosis and other complications.  Ultimately, the successful development 
of a 3D in vitro tissue model will provide a better testing model of new targets for 
preventive and therapeutic interventions of atherosclerosis. 
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PROJECT OBJECTIVES: 
 
1. Develop a 3D model that can mimic the physiology of cells following a 
hyperglycemic episode.  
2. Analyze the changes in the blood endothelium following a hyperglycemic 
episode. 
3. Determine the effect of hyperglycemia on leukocyte migration across the 
endothelium. 
4.  Determine the effect of hyperglycemia on monocyte differentiation into either 
dendritic cells or macrophages. 
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CHAPTER II 
 
 
MATERIALS AND METHODS 
 
2.1 Reagents 
Bovine type I collagen was purchased from INAMED Biomaterials (Fremont, 
CA); collagenase was purchased from Roche (Basel, Switzerland); Ficoll-PaqueTM PLUS 
was purchased from GE Healthcare (Uppsala, Sweden); fetal bovine serum (FBS) and 
trypan blue solution were purchased from Hyclone (Logan, UT); bovine serum albumin 
(BSA), D-mannitol, and glucose assay reagent were purchased from Sigma-Aldrich (St. 
Louis, MO); D-glucose (dextrose), methanol and triton X-100 were purchased from 
Fisher Scientific ( Pittsburgh, PA); human-fibronectin was purchased from Biomedical 
Technologies Inc. (Stoughton, MA); sodium azide was purchased from Acros Organics 
(Geel, Belgium); CellTrackerTM Green, dulbecco’s phosphate buffered solution (DPBS), 
ethidium homodimer-1, media 199 (1X & 10X),  penicillin-streptomycin-glutamine 
(PSG) solution and trypsin-EDTA solution were purchased from Invitrogen Corporation 
(Carlsbad, CA); mouse anti-human fluorochrome-conjugated antibodies CD3, CD19, 
CD14, CD56, CD83, CD206 (macrophage mannose receptor), CD208 (DC-LAMP), 
CD31 (PECAM-1), CD106 (VCAM-1), PgP (MDR), CD64 and appropriate isotype 
controls, were purchased from BD Biosciences (San Jose, CA); mouse anti-human 
fluorochrome conjugated CD14 and the appropriate isotype control were purchased from 
 33 
BioLegend (San Diego, CA); tumor necrosis factor-α (TNF-α), mouse anti-human 
fluorochrome conjugated CD 54(ICAM-1), CD 62E(E-selectin) and the appropriate 
isotype control were purchased from R&D Systems (Minneapolis, MN). 
 
2.2 Cell Culture 
Pooled human umbilical vein endothelial cells (HUVECs) were purchased from 
PromoCell (Heidelberg, Germany).  HUVECs were cultured in Medium 199 containing 
20% FBS and 1% PSG.  Culturing was carried out at 37 °C in a humidified atmosphere 
of 5% CO2 and 95% air (henceforth referred to as standard conditions).  For all 
experiments, the cells were consistently used within five population doublings. The 
typical time required to grow the HUVECs to a number that can be used to create the 
tissue model was approximately seven days. 
Human peripheral blood mononuclear cells (PBMCs) were isolated from the 
blood obtained from healthy donors from the Oklahoma Blood Institute (OBI) 
(Oklahoma City, OK) by using a Ficoll density gradient separation method.  Autologous 
plasma was also obtained from OBI and used as the serum supplement for all 
experiments involving PBMCs.  The glucose concentration of all plasma samples were 
measured to ensure normoglycemia levels. 
 
2.3 Determination of Glucose Concentration in the Plasma Samples of Blood Donors 
 To measure the glucose concentration in the plasma samples, a standard 
enzymatic assay using glucose assay reagent was used.  Glucose is phosphorylated by 
adenosine triphosphate in the reaction catalyzed by hexokinase. Glucose-6-phosphate is 
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then oxidized to 6-phosphogluconatein the presence of oxidized nicotinamide adenine 
dinucleotide (NAD) in a reaction catalyzed by glucose-6-phosphate dehydrogenase.  
During this oxidation, an equimolar amount of NAD is reduced to NADH.  The 
consequent increase in absorbance at 340 nm is directly proportional to glucose 
concentration.  Standard glucose solutions over a wide range (0-10 mM) were made with 
distilled water.  One part of the standard solution is mixed with five parts of the glucose 
assay reagent in cuvets.  These cuvets were incubated for 15 minutes at room 
temperature.  These standards were then transferred to a 96-well plate and the optical 
density of each sample at a wavelength of 340 nm was measured.  A standard plot 
showing optical density as a function of glucose concentration was prepared and showed 
a linear correlation.  This standard plot was used to determine the glucose concentration 
in unknown plasma samples.  Same mixing and incubation procedure were followed with 
the samples, followed by measuring the optical density at 340 nm.  This optical density 
was compared with the standard glucose plot and the unknown glucose concentrations in 
samples were determined. 
 
2.4 Development of 3D Tissue Model  
To prepare the 3D collagen matrix, a collagen solution containing 57.1 vol% type 
1 bovine collagen (3 mg/ml), 7.14 vol% 10x Medium 199, and 35.7 vol% 0.1 M sodium 
hydroxide was added to designated wells of a 48-well plate that would result in an 
approximately 500 µm thick matrix measured by microscopy analysis.  The cushions 
were incubated at standard conditions for 60 minutes for the collagen to gel.  The 
collagen gels were seeded with HUVECs at a density of 100,000 cells/cm2, and the cells 
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were cultured at standard conditions with the same media system described previously.  
The 3D human tissue models were used for testing at one day after the cells became 
completely confluent on the collagen matrix (by microscopic examination).  The typical 
time required for the cells to become confluent for the tissue model to be ready for testing 
was approximately seven days.  Figure 11 shows the development of the 3D tissue model. 
 
Figure 11.  Development of the 3D tissue model in a 96-well plate. Scale bar: 15 µm. 
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2.5 Determination of the Optimal Time to Incubate the 3D Tissue Model with 
Glucose 
 The effect of hyperglycemic conditions on the endothelial cells is a transient 
process.  For example, hyperglycemic conditions can be toxic to the cells, but depends on 
both glucose concentration and cell exposure time to the hyperglycemic conditions.  The 
expression and/or regulation of various CAMs can also depend on both concentration and 
time.  For example, a threshold glucose concentration may be needed to elicit CAM 
expression, but this also takes a certain amount of time for the cells to sense the stimuli 
and then respond, by CAM expression.  Since the goal of this project was to only 
investigate the effect of glucose concentration, a study was performed to find the optimal 
cell exposure time to glucose to elicit a detectable response from the high glucose 
concentrations.  The 3D human tissue model was developed using normal culture media 
(5.6 mM media M199) as described above.  One day post confluency, the endothelial 
cells were incubated with varying glucose concentrations (5.6 mM, 15 mM, 30 mM) for 
3, 9 and 24 hours.  The cells were rinsed three times with DPBS to remove any 
accumulated cell debris and cell aggregates that could interfere with leukocyte migration.  
An equal number of PBMCs, 1.56 x 106 per cm2, in media containing Medium 199 with 
20% autologous plasma and 1% PSG were added to each sample and incubated at 
standard conditions for two hours to allow for initial cell migration into the tissue model.  
After two hours, the samples were rinsed three times with DPBS, in order to remove any 
cells that did not migrate across the endothelium and into the subendothelial space of the 
tissue model.  The samples were cultured in the media containing the autologous plasma 
at standard conditions for 48 hours, to allow for further cell migration and differentiation.  
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The time points chosen for leukocyte migration and differentiation were based on 
previous results from a similar model used to study monocyte migration and 
differentiation under normal conditions [90].  
The following three cell populations were studied for this model: 1) the cells that 
initially migrated into the subendothelium (SE) space of the tissue model after the two-
hour incubation period, called the “SE-2hr” cells, 2) the cells that remained within the SE 
space after the 48-hour incubation period, called the “SE-48hr” cells, and 3) the cells that 
reverse-transmigrated (RT) back across the endothelial layer to the top of the tissue 
model after the 48-hour incubation period, called the “RT” cells.  The individual cell 
populations were collected for analyses.  To collect the RT cells, after the 48-hour 
incubation time, the cells from the top of the HUVEC layer were collected by using a 
micropipettor to gently transfer the cells within several washes with DPBS to collection 
tubes.  To obtain the SE cells, the tissue models made up of collagen were digested using 
collagenase, and the cell suspension filtered through a 40 µm cell strainer to remove the 
larger HUVECs.  Individual migration numbers within the three cell populations were 
counted.  Viability of the cells was also checked by using trypan blue. 
 
2.6 Incubation of 3D Tissue Model with Glucose 
Prior to any testing, the endothelium was rinsed gently with PBS to remove any 
debris from the surface that can interfere with normal cell function.  Media containing 
varying glucose concentrations [5.6, 15, 30 mM (and in some cases 45 mM)] were put on 
designated wells and incubated for nine hours.  The effect of hyperosmolarity associated 
with a high glucose concentration was also investigated by using a hyperosmolar control, 
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mannitol.  The 5.6 mM concentration is the glucose concentration in the standard 
Medium 199 culture media (normoglycemia) and serves as the negative control group for 
the experiments.  The cell incubation time with glucose for all experiments was 
determined from the results of prior experiments and from other studies that show 
endothelial cells respond to cytokines such as IL-1 and TNF-α, by an increase in the 
expression of VCAM-1 with maximal activity reached by 6-12 hours.[96]  Therefore, 
since it is hypothesized that high glucose concentrations will have a similar effect on 
HUVECs, a similar cell incubation time was chosen.  After the nine-hour incubation 
time, the media containing the varying glucose concentrations were removed from the 
wells and standard culture media was used for any further analyses or tests of the 
samples. 
 
2.7 HUVEC Viability Assay 
Viability of the HUVECs was assessed after the nine-hour incubation period of 
the 3D tissue model with varying glucose concentrations.  A sample of cells exposed to 
1% Triton X-100 in the culture medium for the same nine-hour incubation period was 
used as a positive control for dead cells.  At this concentration of Triton X-100, the cell 
membrane is permeabilized, resulting in cell death.  Viability of the cells was determined 
by staining with CellTrackerTM Green (CMFDA) and ethidium homodimer-1.  Cell-
permeant esterase substrates, such as CellTrackerTM Green, serve as viability probes that 
measure both cell-membrane integrity, which is required for intracellular retention of the 
probe and enzymatic activity, which is required to activate the fluorescence of the probe.  
Viable cells were identified by a green fluorescent cytoplasm.  Cell impermeant nucleic 
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acid stains, such as ethidium homodimer-1, were used to detect the dead-cell population.  
This probe was able to penetrate dead cells with compromised membranes, resulting in 
dead cells with red fluorescent nuclei.  The fluorescently stained cells were observed by a 
fluorescent microscope.   
 
2.8 Analysis of the Surface Expression of PECAM-1 and VCAM-1 on HUVECs by 
Confocal Microscopy  
HUVECs were grown on thin collagen gels within wells in chamber slides 
purchased from Nunc Lab-Tek (Rochester, NY ), shown in Figure 12a.  The cells were 
seeded at the same density and grown under the same conditions as those described for 
the development of the 3D human tissue model.  At one day post-confluency of the 
HUVECs, specific wells were incubated with media containing varying glucose 
concentrations (5.6, 15, and 30 mM) for nine hours.  Some wells were also incubated for 
the same time period with TNF-α (100 U/ml) to serve as a positive control for VCAM-1 
expression.  TNF-α is known to activate HUVECs and cause an increase in the 
expression of certain cell adhesion molecules, such as VCAM-1. After the nine-hour 
incubation period, fluorochrome-conjugated antibodies were used to identify PECAM-1 
and VCAM-1 cell-surface expression.  Briefly, the samples were washed with DPBS and 
fixed in methanol at 4 °C for 10 minutes.  The samples were washed with DPBS and 
incubated with a blocking buffer of DPBS containing 1% BSA at room temperature for 
30 minutes.  Appropriate dilutions of the primary antibodies and controls were added to 
the samples and incubated at 37 °C at standard conditions for one hour, after which the 
samples were washed three times with DPBS.  The chamber walls were removed from 
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the slides containing the samples and a cover slip attached, as shown in figure 12. The 
samples were analyzed by confocal microscopy. 
 
Figure 12.  Lab picture showing: a) the 3D tissue models in the chamber slide, b) 
removing the side wells from the plate, c) removing the gasket from the slide. The 
samples are covered with a coverslip and ready for analysis by confocal microscopy. 
 
2.9 Analysis of the Surface Expression of PECAM-1, VCAM-1, ICAM-1 and E-
Selectin on HUVECs by Flow Cytometry 
One day post-confluency of the HUVECs in the 3D tissue models, specific wells 
were incubated with media containing varying glucose concentrations (5.6, 15, 30, 45 
mM) for nine hours.  Some wells were also incubated for the same time period with TNF-
α (100 U/ml) to serve as a positive control, due to TNF-α has been shown to activate 
HUVECs and cause an increase in the expression of certain cell adhesion molecules 
(CAMs). Also, to check if hyperosmolarity plays a significant role in regulating CAM 
expression, a 45 mM mannitol (5.6 mM Glucose + 39.4 mM Mannitol) control group was 
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also included.  After the nine-hour incubation period, the media were removed from the 
samples and the collagen gels were digested with collagenase.  The digested collagen and 
HUVECs were collected and centrifuged to isolate the cells from the collagen solution. 
Cells were washed in blocking buffer (1% BSA in PBS) for 10-15 minutes at 370C.  A 
typical fluorochrome-conjugated antibody panel was selected to identify each type of 
CAM expression on the surface of the HUVECs: Cluster of differentiation 31 (CD 31) for 
PECAM-1 expression, CD 106 for VCAM-1 expression, CD 54 for ICAM-1 expression, 
and CD 62E for E-selectin expression. For immunostaining, the cells in each population 
were collected and rinsed with the staining buffer of DPBS containing 2% FBS and 
0.09% sodium azide.  Next, the cells were incubated with various antibody combinations 
along with the proper isotype controls for 45 minutes at 4 °C.  The cells were washed 
with the staining buffer and analyzed by flow cytometry using FACSCalibur within 24 
hours of staining.  By flow cytometry analysis, the fluorescence intensity for each CAM 
corresponding to each glucose concentration was measured.  The fluorescence intensity 
of each sample was normalized based on the isotype controls fluorescence intensity, and 
the percentage changes in fluorescence intensity corresponding to increasing glucose 
concentrations was determined. 
 
2.10 Analysis of Leukocyte Migration and Monocyte Differentiation within the 3D 
Tissue Model 
To study the effect of high glucose concentration on leukocyte migration and monocyte 
migration, samples were incubated with varying concentrations of glucose (5.6, 15, 30 
and 45) as described in section 2.6.  Control samples for the experiment include the 
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control group for hyperosmolarity (45 mM Mannitol) and endothelial activation (100 
U/ml TNF- α): samples were rinsed three times with DPBS in order to remove any cell 
aggregates from the cell surface that could interfere with leukocyte migration and to 
remove FBS from the samples that could possibly interfere with monocyte 
differentiation.  Figure 13 shows the next steps in the leukocyte migration and 
differentiation model.  An equal number of PBMCs, 1.56 x 106 per cm2, in media 
containing Medium 199 with 20% autologous plasma and 1% PSG were added to each 
sample and incubated at standard conditions for two hours in order to allow for initial cell 
migration into the tissue model.  After two hours, the samples were rinsed three times 
with DPBS in order to remove any non migratory cells remaining on top of the 
endothelial cell layer of the tissue model.  The samples were cultured in media containing 
autologous plasma at standard conditions for 48 hours, to allow for cell migration and 
differentiation.  
 
Figure 13. Leukocyte Migration and Differentiation within the 3D Tissue Model 
The three cell populations that were studied for this model include the following: 1) the 
SE-2hr cells, 2) the SE-48hr cells, and 3) the RT cells, as described previously.  The 
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individual cell populations were collected for analyses.  Cell viability and numbers were 
determined for each group by using trypan blue exclusion and counting with a 
haemocytometer. 
The phenotype of the cells for the three cell populations collected was determined 
by immunostaining and flow cytometry.  A typical antibody panel was selected to 
identify the cell types within the PBMC population, including CD3 for T-cells, CD19 for 
B-cells, CD14 for monocytes, and CD56 for natural killer cells.  To detect macrophages 
or dendritic cells and their possible maturation states in the cell populations, the 
following antibodies were used: CD64, CD83, CD206, and CD208.  To determine the 
potential role of a cell surface molecule in reverse transmigration, the transmembrane 
protein MDR-1 was studied.  Studies have shown that this transmembrane protein is 
important for reverse transmigration of the cells.[90]  For immunostaining, the cells in 
each population were collected and rinsed with the staining buffer of DPBS containing 
2% FBS and 0.09% sodium azide.  Next, the cells were incubated with various antibody 
combinations, along with the proper isotype controls for 45 minutes at 4 °C.  The cells 
were washed with the staining buffer and stored at 4 °C until ready for analysis by flow 
cytometry within 24 hours of staining. 
 
2.11 Statistical Analysis 
 Statistical analyses were performed by use of analysis of variance (ANOVA) 
followed by a student’s t-test.  A value of P < 0.1 was considered significant.  For the 
flow cytometry data, samples were normalized based on the 5.6 mM glucose 
concentration control group, and the percent increases determined.   
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CHAPTER III 
 
 
RESULTS AND DISCUSSION 
 
3.1 Determination of the Optimal Time to Incubate the 3D Tissue Model with 
Glucose   
A time to incubate the 3D tissue model with glucose was to be determined, that 
could elicit a detectable response from the high glucose concentrations.  In order to 
determine the optimal incubation time for the 3D tissue model with glucose, three 
different incubation times (3, 9 and 24 hours) were chosen and the corresponding number 
of leukocytes migrating within the 3D tissue model was determined.  
Figures 14 and 15 show the total number of cells migrating based on the three 
incubation times for SE-2 hr and RT cell types, respectively.  The number of cells 
migrating for the SE-48 hr population was also determined, but showed no significant 
difference among the times tested (data not shown).  Multiple cell counts were performed 
and an average standard deviation of 10% was determined.  The number of cells 
migrating in the SE-2 hr population was significantly greater for the nine-hour incubation 
time, over the three and 24 hour.  A similar effect was seen for RT cells with a significant 
increase in the number of cells migrating for the nine-hour incubation time point.  
Incubation of the 3D tissue model for 3, 9 and 24 hours gave significantly different 
overall cell migration numbers, confirming that glucose incubation time has a role in 
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leukocyte trafficking across the endothelium.  It is important to note that these numbers 
show total cell migration and are not a measure of individual cell types.  Cell 
classification of the total cell migration population was determined and will be discussed 
in the next sections.  Based on these results, it was decided to conduct all future 
experiments with an incubation time of nine hours. 
 
 
Figure 14.  Effect of incubation time of the 3D tissue model with glucose on SE-2hr 
total cell migration numbers. (Shown are average values with s.d. from n=3). 
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Figure 15.  Effect of incubation time of the 3D tissue model with glucose on RT total 
cell migration numbers. (Shown are average values with s.d. from n=3). 
 
3.2 Determination of Glucose Concentration in the Plasma Samples of Blood Donors 
The blood samples used to obtain the PBMCs and plasma for the experiments 
were checked for certain levels of factors that may interfere with the study of cell 
migration and differentiation in response to hyperglycemia, such as plasma glucose and 
cholesterol levels.  It was important to make sure that the leukocytes isolated from the 
blood samples were not facing any abnormal condition before testing.  Cholesterol limits 
were checked in the clinical reports that accompanied the blood samples.  They were all 
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found to be within the normal cholesterol level i.e. within 200 mg/dl (data not shown).  A 
glucose assay was used to determine the plasma glucose concentration of each blood 
sample.  All the blood samples were found to have glucose levels either less than or 
within the normal glucose range of 4 mM to 7 mM i.e. none were hyperglycemic.  Thus, 
the leukocytes were attained from normal physiological condition prior to facing 
experimental conditions. 
   
3.3 HUVEC Viability Assay 
Viability was determined as a measure of fluorescence associated with the 
fluorophores CellTrackerTM Green and ethidium homodimer-1. CellTrackerTM Green is a 
stain for live cells, giving it a bright green color, and ethidium homodimer-1 stains the 
nucleus of the dead cells red.  Figure 16 shows the fluorescent images of the samples that 
were used to determine HUVEC viability after exposure to varying glucose 
concentrations for the nine-hour incubation time.  The images were taken at 100X 
magnification.  Fluorescent intensity of the samples was measured using imaging 
software called ImageJ.  There was no significant difference in fluorescence intensity 
between the negative control sample containing 5.6 mM glucose and the samples with the 
elevated glucose concentrations of 15 and 30 mM for the nine-hour incubation time.  
There was however, a significant difference among the positive control for this analysis, 
the Triton X-100 group, and the other groups.  Thus, for the incubation period of nine 
hours, it was concluded that cell viability is not affected at the hyperglycemic conditions 
tested. 
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Figure 16.  Effect of high glucose on HUVEC cell viability. 
 
3.4 Analysis of the Surface Expression of PECAM-1 and VCAM-1 on HUVECs by 
Confocal Microscopy  
Many in vitro and in vivo studies have shown the surface expression of the cell 
adhesion molecules PECAM-1 [47, 74], and VCAM-1 [74] on HUVECs in the event of 
inflammation.  Since hyperglycemia is thought to be an inflammatory mediator, CAM 
expressions were investigated at hyperglycemic conditions.  The 3D tissue model 
samples in the chamber slides that were exposed to different glucose concentrations were 
stained with PECAM-1 and VCAM-1 antibodies.  The expression of these CAMs was 
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analyzed by using confocal microscopy, to provide a qualitative analysis of the change in 
CAM expression.  
On visual inspection using confocal microscopy, it was found that there was no 
significant difference in PECAM-1 expression for any of the groups that were incubated 
with varying glucose concentrations (data not shown).  All the groups showed expression 
of PECAM-1 along the cell-cell boundaries, thereby confirming the role of PECAM-1 in 
leukocyte trafficking within the 3D tissue model.  This suggests that even though 
PECAM-1 is important in leukocyte trafficking, it is not affected by an increase in 
glucose concentration for this incubation period.  
Figure 17 shows the effect of varying glucose concentrations on VCAM-1 
expression for the HUVECs.  There is no change in VCAM-1 expression for the samples 
exposed to a 15 mM glucose concentration compared to the negative control group that 
was exposed to a 5.6 mM glucose concentration.  However, an increase was observed in 
VCAM-1 expression for the samples exposed to 30 mM glucose concentration compared 
to the negative control group.  Thus, this analysis shows that after attaining a threshold 
value (approximately 30 mM), VCAM-1 is expressed on the endothelial cells.  The 
positive control TNF-α also showed an increase in VCAM-1 expression, even greater 
than that for the 30 mM glucose samples.  
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Figure 17.  Effect of high glucose concentration on VCAM expression on HUVECs 
in the 3D Tissue model 
 
3.5 Analysis of the Surface Expression of PECAM-1, VCAM-1, ICAM-1 and E-
Selectin on HUVECs by Flow Cytometry  
After a qualitative investigation of CAM expression (PECAM-1 and VCAM-1) 
on the HUVECs with immunostaining and confocal microscopy, the next step was to use 
flow cytometry for a more quantitative analysis.  Flow cytometry was used to 
quantitatively measure the expression of each CAM in response to the various glucose 
concentrations tested. Additional CAMs E-Selectin, ICAM-1, were included that may 
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have a potential role in leukocyte trafficking in the 3D tissue model.  Since it appears that 
30 mM is the threshold for CAM expression, an even greater concentration of glucose 
(45 mM) was used to investigate if the expression continues to increase with increasing 
glucose concentration.  The fluorescence intensity of each sample was compared to the 
isotype control fluorescence intensity corresponding to increasing glucose concentrations.  
Figure 18 shows the fluorescence intensity of fluorescently-labeled PECAM-1, 
ICAM-1, E-Selectin and VCAM-1 on the HUVECs in response to an increase in glucose 
concentration and to TNF-α.  PECAM-1 was expressed in all the samples, but there was 
not a considerable difference in the expression that would implicate a dependence on 
glucose concentration for PECAM-1 expression.  This was in agreement with the 
qualitative confocal microscopy method where PECAM-1 expression was not affected by 
increasing glucose concentration.  There was no detectable ICAM-1 expression in any of 
the samples, except for the positive control.  There was no detectable VCAM-1 
expression for the samples exposed to the lower glucose concentrations of 5.6 and 15 
mM, but was significantly enhanced for the higher glucose concentrations of 30 mM and 
45 mM.  Thus, both visual inspection by confocal microscopy (described previously) and 
flow cytometry analysis show that the cells express VCAM-1 once a high glucose 
concentration is reached and then increases proportionally with concentration.  The 
positive control, TNF-α, also showed a VCAM-1 expression quite greater than that of the 
glucose samples.  There was no detectable E-Selectin expression for the samples exposed 
to the various glucose concentrations or to TNF-α.  
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Figure 18.  Fluorescence intensity of fluorescently-labeled PECAM-1, ICAM-1, 
VCAM-1 and E-Selectin on the HUVECs in response to an increase in glucose 
concentration and to TNF-α. 
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Another experiment was used to check for the hyperosmolarity effect that could 
be responsible for the changes in CAM expressions on the HUVECs.  Figure 19 shows 
the histogram of the relative fluorescent intensities corresponding to measured CAM 
expression in response to increasing glucose concentrations and a high concentration of 
mannitol.  PECAM-1 was expressed in all the samples, but there was not a significant 
difference in the expression between mannitol and samples incubated with glucose.  As 
before, ICAM-1 expression was not found in any of the samples, except for the samples 
exposed to TNF-α.  Thus, there was no effect of a high glucose or high mannitol 
concentration on ICAM-1 expression.  There was no VCAM-1 expression on the 
HUVECs exposed to a high mannitol concentration, thus showing that mannitol does not 
cause any significant change to VCAM-1 expression.  There was a problem with the 
staining procedure for the sample exposed to the 45 mM glucose concentration for the 
VCAM-1 analysis, which resulted in no data for this sample.  The HUVECs exposed to 
TNF-α showed an upregulation of VCAM-1 expression.  There was no detectable E-
Selectin expression for any of the samples exposed to either glucose or the 
hyperosmolarity control mannitol.  Thus, the conclusion is that the hyperosmolarity 
control mannitol did not cause any significant change in any of the CAM expressions 
compared to the 5.6 mM negative control. 
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Figure 19.  Fluorescent intensity of fluorescently-labeled PECAM-1, ICAM-1, 
VCAM-1 and E-Selectin expression on the HUVECs in response to a high glucose 
concentration and a high mannitol concentration. 
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3.6 Analysis of Leukocyte Migration and Monocyte Differentiation 
     3.6.1 Overall Leukocyte Migration 
This study investigated leukocyte trafficking into the 3D tissue model in response 
to varying glucose concentrations.  To account for the possible role of hyperosmolarity 
associated with glucose on the 3D tissue model, a hyperosmolarity control, mannitol, was 
used as well.  Upon incubation of the 3D tissue model with different glucose 
concentrations for the nine hour incubation time, the three groups of cells were collected 
and counted: 1) SE-2 hr: cells that migrate into the subendothelium region of the tissue 
model after a 2-hour incubation period; 2) SE-48 hr: cells that remain within the 
subendothelium after an additional 48-hour incubation period; and 3) RT: cells that 
reverse-transmigrate across the endothelium after the 48-hour incubation period. 
Figure 20 shows the total cell migration numbers in all these three groups in 
response to increasing glucose concentration.  The SE-2hr group shows that there was an 
increase in initial cell migration into the tissue model, proportional to increasing glucose 
concentration.  The SE-48 hr group also shows a significant increase in the number of 
cells remaining within the subendothelium after 48 hours, proportional to increasing 
glucose concentration, with the model exposed to 30 mM glucose concentration showing 
a significant increase compared to the 5.6 mM control group.  There was no significant 
difference in cell migration numbers for the RT group in response to increasing glucose 
concentration. Multiple cell counts were done using a hemacytometer with the standard 
deviation associated with each count at approximately 10%.  After counting, 
immunofluorescence was used to label certain cell markers and flow cytometry analysis 
 56 
was performed on each group of cells, to count and classify each of the leukocyte species 
present in each. 
 
Figure 20. Cell migration in the 3D tissue model in response to incubation with 
various concentrations of glucose. (Shown are average values with s.d. from n=3). 
Flow cytometry analysis was performed to determine the individual leukocyte 
species present in the pool for each of SE-2hr, RT, and SE-48hr group of cells: CD3+ (T 
cells), CD14+ (Monocytes), CD83+/CD206- (Immature DCs), CD83-/CD206+ 
(Macrophages), CD83+/CD208+ (Mature DCs), CD64+(Monocytes or macrophages). 
Initial studies with the 3D tissue model showed no CD19+ (B cells) or CD56+ (natural 
killer cells) cells in any of the cell populations (data not shown).  
Flow cytometry analysis also was used to measure MDR-1 expression on the 
leukocytes.  MDR-1 is a well known transporter molecule, often studied for its possible 
mediatory role in efflux and influx of chemotherapeutic agents and cell transportation.  
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Though it is known that these molecules are expressed by leukocytes and endothelial 
cells under activation, the complete physiological functions of the molecules are poorly 
defined.  A recent study [90] showed a possible role of MDR-1 in basal to apical 
transendothelial migration of leukocytes. This role of MDR-1 was investigated for in the 
3D tissue model.   
 
     3.6.2 Leukocyte Migration and Monocyte Differentiation: SE-2 hr Cells 
Figure 21 describes the percent increase in cell migration of certain cell markers 
with an increase in glucose concentration.  The numbers are normalized with respect to 
the 5.6 mM glucose concentration control group.  Within the SE-2 hr group, an increase 
in glucose concentration was found to increase CD14+ (monocyte) migration into the 
intima, along with an increase in CD83+/CD206- (immature DCs) population.  A 
significant increase in CD3+ (T cell) population with a higher glucose was also observed 
for the SE-2 hr group.  There was an increase of approximately 40% when exposed to 15 
mM, and 100 % when exposed to 30 mM compared to the control group of 5.6 mM.  This 
was a very significant development showing an enhanced initial migration of T cells, 
when exposed to an inflammatory condition (in this case, hyperglycemia).  For the 
CD14+ monocyte population, a glucose increase to 15 mM showed a 30% increase, and a 
further glucose increase to 30 mM, resulted in a 55% increase in monocyte migration 
compared to the control group of 5.6 mM.  The CD 83+/206- population dd not show a 
significant increase at lower glucose concentrations, but showed a 70% increase 
compared to the 5.6 mM control group when exposed to a high 30 mM glucose. This 
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finding indicates the possible differentiation of monocytes into immature DCs; however, 
this combination of markers can also be found on the monocytes as well.    
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Figure 21.  Average percent increase in certain cell markers for SE 2 hour cells after 
the 3D tissue model was exposed to high glucose concentrations. (n=2) 
The 3D tissue model was also tested with a higher concentration of glucose (45 
mM) and a mannitol control.  In this test, the expression of MDR-1 and CD64+ 
(monocyte or macrophage population) was also investigated for the groups of cells 
collected from the model. Figure 22 shows the percent increase for each cell marker and 
MDR-1 expression, in response to increasing glucose concentration.  The numbers are 
normalized with respect to the control group of 5.6 mM glucose.  
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An increase in glucose concentration from 5.6 mM to 15 mM resulted in 
approximately 45%, 35% and 65% increase in CD3+ (T cell), CD14+ (monocyte) and 
CD64+ (monocytes or macrophages) populations, respectively.  The expression of MDR-
1 at 15 mM increased by approximately 20%, compared to the 5.6 mM control group.  
Compared to the 5.6 mM glucose concentration, exposure to the 30 mM glucose 
concentration resulted in approximately 100%, 60%, 65% and 60% increase in CD3+ (T 
cell), CD14+ (monocyte), CD83+/CD206- (immature DCs) and CD64+ (monocytes or 
macrophages) populations, respectively.  At this glucose concentration, MDR-1 
expression was also increased by 125%, compared to the control group 5.6 mM glucose.  
An increase in glucose concentration from 5.6 mM to 45 mM resulted in 
approximately 140%, 75%, 85% and 45%  increase in CD3+ (T cell), CD14+ 
(monocyte), CD83+/CD206- (immature DCs) and CD64+ (monocytes or macrophages) 
populations, respectively.  Exposure to 45 mM resulted in a 280% increase in MDR-1 
expression, compared to the 5.6 mM control group.  
For MDR-1, mannitol was found to have an effect close to that measured for the 
15 mM glucose concentration.  Also, the effect of mannitol on all cell population 
migration numbers was less than the effect produced by the 30 mM glucose 
concentration.  This reflects a relatively small role that hyperosmolarity has on initial 
migration of these cell populations into the subendothelial space.  Thus, the role of 
mannitol was not completely negligible, but definitely not comparable to the effect from 
the high glucose concentration. 
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Figure 22.  Percent increase in certain cell markers for SE 2 hr cells exposed to high 
glucose concentrations and the hyperosmolarity control, mannitol.  
 
     3.6.3 Leukocyte Migration and Monocyte Differentiation: RT Cells 
Figure 23 describes the percent increase of certain populations from the cells that 
reverse transmigrated from the tissue model in response to an increase in glucose 
concentration.  The numbers are normalized with respect to the 5.6 mM control.  Within 
the RT group, an increase in glucose concentration was found to increase CD3+ (T cell) 
and CD83+/CD206- (immature DCs) cells.  For the CD3+ T cell population, there was 
observed an increase of approximately 40% when exposed to 15 mM, and 110 % when 
exposed to 30 mM compared to 5.6 mM glucose concentration.  There was a significant 
 61 
increase in CD83+/206- immature dendritic cell population of 25% for 15 mM and 50% 
increase for 30 mM compared to the control group.  These numbers indicates a higher 
degree of immature dendritic cells found in the reverse transmigrating cells, when 
exposed to higher glucose concentrations.  It is believed that these are indeed immature 
dendritic cells, since CD14 was no longer expressed.  This could possibly be tied to the 
fact that more monocytes migrated into the tissue model; therefore, more will reverse-
transmigrate back out and differentiate into dendritic cells.  This possibly shows that a 
higher glucose concentration, serves as a more severe injury condition, and promotes 
more iDCs to be formed.  
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Figure 23.  Average percent increase in certain cell markers for RT cells after the 
3D tissue model was exposed to high glucose concentrations. (n=2). 
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The 3D tissue model was also tested with a higher concentration of glucose (45 
mM) and a hyperosmolarity control, mannitol.  The expression of MDR-1 and CD64+ 
(monocyte or macrophage population) was investigated in response to an increase in 
glucose concentration.  Figure 24 shows the percent increase for each cell marker and 
MDR-1 expression, in response to increasing glucose concentration.  The numbers are 
normalized with respect to the control group, 5.6 mM glucose.  
An increase in glucose concentration from 5.6 mM to 15 mM resulted in 
approximately 60%, 30% and 50% increase in CD3+ (T cell), CD83+/206- (immature 
dendritic cells) and CD64+ (monocytes or macrophages) populations, respectively.  The 
expression of MDR-1 for the 15 mM glucose sample increased by approximately 20%, as 
compared to the 5.6 mM control group.  
Compared to the 5.6 mM control group, the 30 mM glucose concentration group 
resulted in approximately 130%, 55%, and 50% increase in CD3+ (T cell), 
CD83+/CD206- (immature DCs) and CD64+ (monocytes or macrophages) populations, 
respectively.  At this glucose concentration, MDR-1 expression was also increased by 
10%, compared to the 5.6 mM glucose control group.  
An increase in glucose concentration from 5.6 mM to 45 mM resulted in 
approximately 225%, 85%, and 175%  increase in CD3+ (T cell), CD83+/CD206- 
(immature DCs) and CD64+ (monocytes or macrophages) populations, respectively.  
Exposure to the 45 mM glucose concentration resulted in an 80% increase in MDR-1 
expression, compared to the control group.  
Mannitol was found to have an effect similar to that of the 5~15 mM glucose 
concentration groups.  This shows a relatively small role of hyperosmolarity in the 
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reverse-transmigration of these cell populations.  Thus, the role of mannitol was not 
completely negligible, but not as significant as the response to the high glucose 
concentration. 
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Figure 24.  Percent increase in certain cell markers for RT cells exposed to high 
glucose concentrations and the hyperosmolarity control, mannitol. 
 
     3.6.4 Leukocyte Migration and Monocyte Differentiation: SE-48 hr Cells 
Individual cell populations found in the SE-48 hr group of cells were also 
examined.  Figure 25 describes the percent increase in the number of cells for certain cell 
markers associated with an increase in glucose concentration.  The numbers are 
normalized with respect to the 5.6 mM glucose concentration control.  An increase in 
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glucose concentration was found to increase CD3+ (T cell), CD14+ (monocyte) and 
CD83-/CD206+ (macrophages) populations remaining within the subendothelial space 
after 48 hours.  For the CD3+ (T cell) population, there was an increase of approximately 
70% for the 15 mM group, and 225 % for the 30 mM group compared to the 5.6 mM 
glucose concentration control group.  For the CD14+ monocyte population present within 
the subendothelial space after 48 hours, an increase to 15 mM glucose concentration 
resulted in an increase of approximately 15%.  A further increase to 30 mM glucose 
concentration resulted in a 25% increase. The CD 83-/206+ macrophages cell population 
showed a significant increase compared to the control group of approximately 20% for 
the 15 mM group.  This was further increased to 45% for the 30 mM glucose group. This 
was different compared to the SE-2 hr group, where there were a negligible number of 
macrophages.  For the SE-2 hour cell group, monocytes may not have been able to 
differentiate into macrophages within the first two hours.  This finding indicates the 
possible differentiation of monocytes into macrophages within the 3D tissue model for 
the 2~48 hour time frame.  
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Figure 25.  Average percent increase in certain cell markers for SE 48 hour cells 
after the 3D tissue model was exposed to high glucose concentrations. (n=2). 
 
The 3D tissue model was also tested with a higher concentration of glucose (45 
mM) and a hyperosmolarity control, mannitol, and the SE-48 hr cell group was 
characterized.  The expression of MDR-1 and CD64+ (monocyte or macrophage 
population) cells were also detected in response to an increase in glucose concentration. 
Figure 26 shows the percent increase in number of cells for each cell marker and for 
MDR-1 expression, in response to increasing glucose concentration.  The numbers are 
normalized with respect to the 5.6 mM glucose control group.  
An increase in glucose concentration from 5.6 mM to 15 mM resulted in 
approximately 50%, 25%, 25% and 20% increase in CD3+ (T cell), CD14+ (monocyte), 
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CD83-/206+ (macrophages) and CD64+ (monocytes or macrophages) populations, 
respectively.  The expression of MDR-1 at 15mM increased by approximately 35%, 
compared to the 5.6 mM control group.  
Compared to the 5.6 mM glucose concentration group, the 30 mM glucose 
concentration group showed approximately 170%, 20%, 40% and 50% increase in CD3+ 
(T cell), CD14+ (monocyte), CD83-/CD206+ (macrophages) and CD64+ (monocytes or 
macrophages) populations, respectively.  At this glucose concentration, MDR-1 
expression also increased by 35%, compared to 5.6 mM glucose control group.  
An increase in glucose concentration from 5.6 mM to 45 mM resulted in 
approximately 380%, 75%, 100% and 80%  increase in CD3+ (T cell), CD14+ 
(monocyte), CD83-/CD206+ (macrophages) and CD64+ (monocytes or macrophages) 
cell populations, respectively.  Exposure to the 45 mM glucose concentration resulted in 
a 60% increase in MDR-1 expression, compared to the control group.  
For the mannitol group, the expression of MDR-1 was similar to that for the 15 
mM glucose concentration group.  The effect of mannitol on all cell migration numbers 
was also similar to the 15 mM glucose concentration group.  This shows a relatively 
small role of hyperosmolarity towards cell migration and retention of these cell 
populations within the subendothelial space.  Thus, the role of mannitol was not 
completely negligible, but definitely not comparable to the effect seen for the high 
glucose concentration groups.  
The expression of CD64+ (monocytes or macrophages) was shown to increase 
with increasing glucose concentration.  This shows an increasing number of macrophages 
that remain within the subendothelial space.  After 48 hours, most monocytes have 
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already differentiated to either dendritic cells or macrophages, and the cells that are 
expressing CD64, are macrophages. 
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Figure 26.  Percent increase in certain cell markers for SE 48 hr cells exposed to 
high glucose concentrations and the hyperosmolarity control, mannitol. 
The number of CD83+/CD206- (immature DCs) cells in the SE-48 hr group of 
cells was found to be much lower compared to the RT cell group.  This observation is 
related to the nature of the dendritic cells, which are known to migrate towards the 
lymphatics in vivo.  Thus, at the end of 48 hours, more immature DCs have already 
reverse transmigrated across the endothelium and were collected in the RT group of cells, 
and few remain within the SE-48 hr group.
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CHAPTER IV 
 
 
CONCLUSIONS AND FUTURE RECOMMENDATIONS 
 
The present research project used a 3D tissue model exposed to high glucose 
concentrations in order to investigate the effect of hyperglycemia on endothelial cell 
dysfunction and on immune cell trafficking and differentiation.  The main conclusions of 
the project are: 
1. A 3D tissue model was successfully created that was used to investigate the effect 
of hyperglycemia on endothelial cells and leukocyte migration and differentiation. 
2. For the time periods tested, endothelial viability was not significantly affected in 
the 3D tissue model by incubation with high glucose concentrations.  
3. Increasing glucose concentrations resulted in increase in VCAM-1 expression on 
endothelial cells, indicating that this adhesion molecule plays a possible role in 
leukocyte recruitment for the tissue model.  An increase in glucose concentration 
to a threshold of 30 mM was shown to increase VCAM-1 expression on 
endothelial cells.  The expression of PECAM-1 on the endothelial cells was not 
affected by increasing glucose concentrations. 
4. For the initial migration of leukocytes across the endothelium and into the 
subendothelial space, the T cell, monocytes and immature dendritic cell 
populations increased with increasing glucose concentrations.  There was a slight 
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5. increase for the 15 mM concentration and significant increases for the 30 mM and 
45 mM concentrations. 
6. For the group of cells undergoing reverse transmigration out of the subendothelial 
space at a later time point, an increase in glucose concentration resulted in an 
increase of monocyte and immature dendritic cell populations.  
7. For the cells remaining within the subendothelial at a later time point, there was 
an increase of T cell, monocyte, and macrophages populations, relative to 
increasing glucose concentrations.  The T cell population was greatly increased 
for the high glucose concentration of 45 mM. 
The main objective of this research was to develop a 3D tissue model to simulate 
the blood endothelium and subendothelial space that could be used to test the effect of 
hyperglycemia on endothelial cells and leukocyte migration and differentiation. The lack 
of experimental models to study the behavior of these cells within a 3D environment that 
can recapitulate in vivo conditions was the major driving force for this project.  The 3D 
tissue model developed for this project can be used as a powerful research tool to study 
various mechanisms associated with the blood endothelium, like the relationship between 
diabetes and atherosclerosis, or as a potential testing device for the therapeutics.  
Unlike human or animals models, which are difficult to control due to their 
multivariant, very transient microenvironment, an in vitro tissue model like the one used 
for this research, offers better control over the system to be studied.  The in vitro 3D 
tissue model can also be used to study anything that would have potential health hazards 
to humans and could not be studied in vivo.  
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The advantage of being 3D gives the tissue model an edge over the present 2D 
cell models.  The 2D models can only be used to investigate leukocyte-endothelium 
interactions, like the leukocyte rolling and adhesion, where a subendothelial space is not 
required.  The 2D models cannot be used to study phenomena like transendothelial 
migration.  Membrane plates (Transwell®) have been used to study transendothelial 
migration, but they lack the important 3D environment that can be used to study cell-
matrix interactions.  These interactions are important for the leukocytes to function 
normally, as they would in vivo.  Because the 2D models lack the sub-endothelial space, 
they cannot be used to study cell migration and differentiation within the subendothelial 
space, at different time points.  Cell migration and differentiation within the 
subendothelial space can be studied in the 3D model.  The novel 3D model also has the 
advantage of being able to arrest the leukocyte species at any time point, in order to study 
the kinetics of the model.  This is especially useful since the end state of a blood 
monocyte traversing the endothelium is very difficult to characterize, due to its transient 
behavior that is dependent on the inflammatory stimulus and the tissue involved.    
A novel 3D model was developed that can mimic the behavior of cells under both 
normal and pathological conditions.  The model is composed of human blood endothelial 
cells cultured on top of a collagen matrix within a multi-well plate format.  The 3D model 
simulates the endothelium and subendothelial space existing in a blood vessel.  Peripheral 
blood mononuclear cells were used to study the leukocyte trafficking through the 
endothelium.  Two time points based on Randolph’s work [90] were chosen to investigate 
the initial migration of cells into the subendothelial space (SE2hr), the later migration of 
cells that are either reverse-transmigrating back out of the subendothelial space after 48 
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hours (RT) or remaining within the subendothelial space after 48 hours (SE48hr).  It was 
important to characterize the tissue model before using it to test different experimental 
conditions.  To represent the hyperglycemic conditions that exist in vivo, an optimal time 
to incubate the 3D tissue model with various concentrations of glucose was determined 
that would be able to evoke a sufficient activation in the endothelial cells and leukocytes.  
Three incubation time periods (3, 9, and 24 hours) were chosen and leukocyte migration 
through the endothelium was studied for these three incubation times.  A nine hour 
incubation time resulted in enhanced leukocyte migration across the endothelium. All 
following experiments were based on this incubation time.  Varying glucose 
concentrations were chosen in order to represent normoglycemia and various levels of 
hyperglycemia that would be seen in diabetics.  
The effect of high glucose concentrations on endothelial cell behavior was studied 
within the 3D tissue model.  Cell viability and the expression of a number of CAMs were 
investigated under increasing glucose concentrations.  There was no significant decrease 
in cell viability for the incubation time of nine hours that was chosen for the model.  
Some studies have shown that high glucose concentrations like the ones chosen for this 
research does affect cell viability [70, 71], but only when exposed for longer time periods 
like 48 hours [97]. 
To determine the effect of high glucose concentrations on CAM expression on the 
endothelial cells, the following were detected by immunofluorescence and flow 
cytometry analysis: PECAM-1, VCAM-1, ICAM-1 and E-selectin.  Among the CAMs 
tested, the expression of VCAM-1 increased for the samples exposed to a minimum 
threshold glucose concentration (30 mM).  The expression of VCAM-1 increased in 
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response to even higher glucose concentration (45 mM), thereby suggesting that VCAM-
1 expression is proportional to glucose concentration, after crossing a threshold glucose 
concentration.  This suggests that enhanced leukocyte migration in response to high 
glucose concentration may be due to the upregulation of VCAM-1 expression.  
The effect of high glucose concentration on initial leukocyte trafficking in the 3D 
tissue model was investigated.  The initial migration of monocytes (SE2hr) into the 
subendothelial space was increased in response to increasing glucose concentration.  
Also, with an increase in glucose concentration, there was an increase in the number of 
immature dendritic cells migrating into the sub endothelial space.  This shows glucose to 
be proinflammatory, resulting in an increase in leukocyte migration across the 
endothelium.  An increase in MDR-1 expression on the leukocytes was also found, which 
has been found to be involved in enhancing leukocytes migration into the lymphatics in 
vivo.[54]  With reference to the 3D tissue model, a cell population expressing MDR-1 
would mean these cells are looking to reverse-transmigrate across the endothelium. 
The effect of high glucose concentration on cells that initially migrate into the 
subendothelial space and then reverse-transmigrate back across the endothelium was 
investigated.  An increase in the number of immature dendritic cells in response to an 
increase in glucose concentration was observed.  The function of dendritic cells in the 
immune system is to act as antigen presenting cells by taking up antigen and presenting it 
to other immune cells, such as T cells, to elicit a response.  To do this, they have to 
migrate to the lymph nodes, where the T cells are found, by way of the lymphatics.  Thus, 
an increase in immature dendritic cells with an increase in glucose concentration suggests 
an increased immune response to the proinflammatory conditions.  An increase in MDR-
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1 expression for the reverse transmigrated cells was also found, which has been 
implicated in leukocyte migration towards lymphatics.[90]  With reference to the 3D 
model, an increase in MDR-1 would result in an increase of leukocytes migrating out of 
the subendothelial space, by reverse transmigration across the endothelium (as if moving 
towards the lymphatics). 
There was an increase in the number of macrophages within this group of cells 
with an increase in glucose concentration.  Macrophages are developed from the 
differentiation of monocytes and are involved in foam cell formation within the 
subendothelium.  These macrophages take up low density lipoproteins (LDL) and cell 
debris from the blood to form foam cells.  These foam cells result in plaque formation, 
which is a hallmark of atherosclerosis.  Thus, an increase in the number of macrophages 
could be an early indicator of plaque formation.  The expression of MDR-1 was much 
less in this category of cells compared to the “SE2hr” and “RT” group of cells.  Most of 
the leukocyte species expressing MDR-1 have already reverse transmigrated out of the 
subendothelial space by this time.  
The present 3D tissue model has successfully been used to study the early effects 
of hyperglycemia on endothelial cell function and leukocyte migration and 
differentiation.  However, to further characterize the early steps associated with plaque 
formation in atherosclerosis and to further develop a model that can be used to test 
therapeutics, future work must be directed towards: 
• Similar to in vivo conditions for diabetics, examine the effect of cyclic episodes of 
hyperglycemia on the kinetics of leukocyte migration and differentiation.  In vivo, 
there is a postprandial glucose rise in the blood.  Slowly, this glucose is either 
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stored as glycogen in the liver or metabolized for energy.  Thus there is cyclic 
increase and decrease of blood glucose.  To study this phenomenon, the 3D tissue 
model would be exposed to cycles of low and high glucose media. 
• Add lipoproteins to the model and investigate LDL uptake by the cells in the 3D 
tissue model.  In atherosclerotic conditions, lipoproteins are phagocytosed by 
macrophages and start depositing along with other cellular debris as plaques.  The 
present model could be used to investigate the early signs of foam cell formation 
that would lead to plaque formation.  To study this phenomenon, LDL would be 
added along with a high glucose concentration, and then LDL uptake would be 
monitored in response to increase in glucose.  
• Increase the complexity of the tissue model by the addition of smooth muscle 
cells and investigate their role in atherosclerosis.  In the event of inflammation, 
there is the migration and proliferation of smooth muscle cells.  An excessive 
inflammatory responses can lead to thickening of the arterial wall, thereby 
forming atherosclerotic lesions.[98] 
• Validate the 3D tissue model by testing known inhibitors of the mechanisms 
associated with atherosclerosis, so that the model can be used to test new 
treatments of the disease. 
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Scope and Method of Study: Leukocytes are known to migrate across an endothelium 
continuously but this migration is enhanced in case of certain inflammatory 
signals, such as those associated with hyperglycemia.  Currently, there have not 
been any studies to characterize the transient behavior of leukocyte migration and 
differentiation in response to hyperglycemia.  A 3D human vascular tissue model 
has been developed to investigate the effect of high glucose concentrations first, 
on endothelial cell behavior and second, on leukocyte trafficking and 
differentiation.  The 3D tissue model was exposed to varying glucose 
concentrations of 5.6, 15, and 30 mM for an optimal incubation time of nine 
hours.  The effect of glucose on endothelial cell viability, expression of cell 
adhesion molecules (CAMs) on endothelial cells, and leukocyte trafficking and 
differentiation within the 3D tissue model was studied.   
 
Findings and Conclusions:  Endothelial cells incubated with high glucose concentrations 
for nine hours showed no significant decrease in cell viability compared to cells 
incubated at a normal glucose concentration of 5.6 mM.  Among the different 
CAMs tested, only VCAM-1 showed a significant change in expression in 
response to the high glucose concentrations.  An increase in glucose concentration 
affected leukocyte migration and differentiation patterns within the 3D tissue 
model.  There were significant increases in certain cell populations for the 3D 
tissue model exposed to 30 mM glucose, compared to the control at 5.6 mM.  For 
the cells undergoing initial migration across the endothelium into the 
subendothelial space, T cell and monocyte cell populations increased by 140% 
and 75%,  respectively.  For the cells undergoing reverse-transmigration across 
the endothelium, the immature dendritic cell population increased by 80%.  For 
the cells remaining within the subendothelial space, T cell and macrophage cell 
populations increased by 380% and 100%, respectively.  
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